692754-97-5Relevant academic research and scientific papers
SULFONAMIDE COMPOUNDS TARGETING CD73 AND ADENOSINE RECEPTORS
-
Page/Page column 59-60, (2021/06/04)
The present invention relates to bispecific compound of formula (I) as dual inhibitors of CD73 and adenosine receptors. The present invention also relates to pharmaceutical compositions comprising said compounds or a pharmaceutically acceptable salt or a stereoisomer or a prodrug thereof and use of such compounds in the treatment of diseases mediated by CD73 and/or adenosine receptors, particularly A2aR or A2bR.
